Brand Engagement Network, Inc. (Nasdaq: BNAI) stock rose 108.75% following the announcement of the AI Pharma deal. The stock price rose to $2.51, and the intraday market cap as of yesterday, December 29, is $13.40 million. Brand Engagement Network closed at $1.20 in the prior session, and the stock nearly doubled yesterday. The analyst’s price target for the next 12 months is $20.
Brand Engagement Network Lands AI Pharma Deal
Brand Engagement Network (Nasdaq: BNAI) (“BEN”) provides conversational AI technology and human-like AI avatars for the enterprise. ‘Entered into a Vendor Services Project Agreement with a leading global advertising and communications agency, a unit of one of the world’s top advertising holding companies, for the development of a custom AI engagement communication method for a top 10 global pharmaceutical client’s established prescription pharmaceutical drug,’ read the press release published yesterday, December 29.
Tyler Luck, Acting Chief Executive Officer of BEN, stated that the agreement reflected the company’s progress in healthcare, where its technology provides trusted, secure, and efficient AI solutions for pharmaceutical manufacturers, healthcare providers, and patients, adding that Brand Engagement Network remains committed to creating consumer experiences that deliver accuracy, reliability, and integrity.
According to the agreement, the Brand Engagement Network is expected to earn $250,000 in revenue in the fourth quarter. The company is also anticipating monthly recurring license fees in the first quarter of 2026.
The Expanding Footprint of Brand Engagement Network
Brand Engagement announced the formation of a new joint venture named Skye Salud with Skye Inteligencia to create a sovereign augmented-intelligence platform for healthcare in Mexico.
“Skye Salud aligns with BEN’s strategy in regulated industries and will be developed to support ongoing efforts to strengthen clinical infrastructure,” stated Tyler Luck, acting CEO.
Skye Salud is a Spanish-language native system that aims to modernize healthcare by integrating clinics and supporting medical workflows in the Latin American country. Despite the strategic deals and expanding footprint, the company recorded elevated volatility in the past year.
Performance of Brand Engagement Network, Inc.(BNAI) in 2025
BNAI showed extreme volatility throughout 2025, marked by sharp price swings and uneven volume. After a steep -64.68% decline in Q1 2025 from elevated levels, the stock rebounded in Q2 (+27.91%) alongside a surge in trading activity, but failed to sustain momentum. Losses resumed in Q3 (-33.18%), followed by an unusually high-volume Q4 2025 selloff (-14.80%), where volume spiked to nearly 247 million shares, suggesting capitulation or heavy repositioning by the stock market rather than orderly trading.
| Date | Open | High | Low | Close | Adj. Close | Change | Volume |
|---|---|---|---|---|---|---|---|
| Q4 2025 | 2.85 | 9.45 | 1.18 | 2.51 | 2.51 | -14.80% | 246,997,052 |
| Q3 2025 | 4.3 | 4.6 | 2.86 | 2.94 | 2.94 | -33.18% | 2,838,769 |
| Q2 2025 | 3.47 | 7.56 | 2.31 | 4.4 | 4.4 | 27.91% | 41,597,438 |
| Q1 2025 | 8.9 | 11.1 | 3.03 | 3.44 | 3.44 | -64.68% | 27,328,383 |
| Q4 2024 | 10.3 | 11.8 | 6.61 | 9.74 | 9.74 | -6.35% | 5,939,733 |
